Li Wu

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 6

Top Topics

Induced Apoptosis

Molecularly Imprinted

Cell Cycle Arrest

Top Venues

Journal of cellular biochemistry

BioFactors (Oxford, England)

Journal of separation science

Molecular pharmaceutics

This page only lists publications with an associated author ORCID identifier.

Publications

Yong Jiang, Liu Xu, Nina Wei, Rui Chen, Yutong Wang, Li Wu, Wei-Dong Li, Zheng Yan, Linwei Chen, Zhipeng Chen
Comparative pharmacokinetics of 11 major bioactive components between two dosage forms of Qixue Shuangbu Prescription in rats by ultra-high-performance liquid chromatography-tandem mass spectrometry. Journal of separation science (2023)
Honglin Chen, Furong Yang, Chuankui Fu, Zimeng Zhang, Kejia Xu, Shengfeng Lu, Zhipeng Chen, Li Wu, Weidong Li
Study on the material basis of Dahuang Zhechong pill of anti-hepatoma effect by promoting vascular normalization. Biomedical chromatography : BMC 36 (5) (2022)
Li Wu, Yan Shi, Zihui Ni, Tao Yu, Zhipeng Chen
Preparation of a Self-Assembled Rhein-Doxorubicin Nanogel Targeting Mitochondria and Investigation on Its Antihepatoma Activity. Molecular pharmaceutics (2021)
Li Wu, Xiao Liu, Ke Xin Cao, Zi Hui Ni, Wei Dong Li, Zhi Peng Chen
Synergistic antitumor effects of rhein and doxorubicin in hepatocellular carcinoma cells. Journal of cellular biochemistry 121 (10) (2018)
Li Wu, Jiayu Zhao, Kexin Cao, Xiao Liu, Hao Cai, Jiaqi Wang, Weidong Li, Zhipeng Chen
Oxidative phosphorylation activation is an important characteristic of DOX resistance in hepatocellular carcinoma cells. Cell communication and signaling : CCS 16 (1) (2018)
Li Wu, Kexin Cao, Zihui Ni, Shaodong Wang, Weidong Li, Xiao Liu, Zhipeng Chen
Rhein reverses doxorubicin resistance in SMMC-7721 liver cancer cells by inhibiting energy metabolism and inducing mitochondrial permeability transition pore opening. BioFactors (Oxford, England) 45 (1) (2018)